Risk-benefit analysis of surgical treatment strategies for cystic craniopharyngioma in children and adolescents

被引:2
|
作者
Schmutzer-Sondergeld, Michael [1 ]
Quach, Stefanie [1 ]
Niedermeyer, Sebastian [1 ]
Teske, Nico [1 ]
Ueberschaer, Moritz [1 ]
Schichor, Christian [1 ]
Kunz, Mathias [1 ]
Thon, Niklas [1 ]
机构
[1] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Neurosurg, Munich, Germany
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
craniopharyngioma; stereotaxy; cyst drainage; microsurgery; endocrinological outcome; visual outcome; QUALITY-OF-LIFE; PEDIATRIC CRANIOPHARYNGIOMAS; CHILDHOOD CRANIOPHARYNGIOMA; THERAPEUTIC OPTIONS; MANAGEMENT; SURGERY; IRRADIATION; OBESITY; ADULTS;
D O I
10.3389/fonc.2024.1274705
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Treatment strategies for craniopharyngiomas are still under debate particularly for the young population. We here present tumor control and functional outcome data after surgical treatment focusing on stereotactic and microsurgical procedures for cystic craniopharyngiomas in children and adolescents. Methods: From our prospective institutional database, we identified all consecutive patients less than 18 years of age who were surgically treated for newly-diagnosed cystic craniopharyngioma between, 2000 and, 2022. Treatment decisions in favor of stereotactic treatment (STX) or microsurgery were made interdisciplinary. STX included aspiration and/or implantation of an internal shunt catheter for permanent cyst drainage. Microsurgery aimed for safe maximal tumor resections. Study endpoints were time to tumor recurrence (TTR) and functional outcome including ophthalmological/perimetric, endocrinological, and body-mass index (BMI) data. Results: 29 patients (median age 9.9 yrs, range 4-18 years) were analyzed. According to our interdisciplinary tumor board recommendation, 9 patients underwent stereotactic treatment, 10 patients microsurgical resection, and 10 patients the combination of both. Significant volume reduction was particularly achieved in the stereotactic (p=0.0019) and combined subgroups (p<0.001). Improvement of preoperative visual deficits was always achieved independent of the applied treatment modality. Microsurgery and the combinational treatment were associated with higher rates of postoperative endocrinological dysfunction (p<0.0001) including hypothalamic obesity (median BMI increase from 17.9kg/m(2) to 24.1kg/m(2), p=0.019). Median follow-up for all patients was 93.9 months (range 3.2-321.5 months). Recurrent tumors were seen in 48.3% and particularly concerned patients after initial combination of surgery and STX (p=0.004). In here, TTR was 35.1 +/- 46.9 months. Additional radiation therapy was found indicated in 4 patients to achieve long-lasting tumor control. Conclusion: In children and adolescents suffering from predominantly cystic craniopharyngiomas, stereotactic and microsurgical procedures can improve clinical symptoms at low procedural risk. Microsurgery, however, bears a higher risk of postoperative endocrine dysfunction. A risk-adapted surgical treatment concept may have to be applied repeatedly in order to achieve long-term tumor control even without additional irradiation.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Hormones and cancer: Risk-benefit analysis
    Sevelda, P
    Salzer, H
    GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1998, 38 (02): : 61 - 63
  • [42] QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB
    Steiner, Israel
    NEUROLOGY, 2009, 72 (20) : 1791 - 1791
  • [43] Risk-benefit analysis of fish consumption
    Leblanc, Jean-Charles
    Sirot, Veronique
    Volatier, Jean-Luc
    CAHIERS DE NUTRITION ET DE DIETETIQUE, 2009, 44 (04): : 182 - 188
  • [44] A risk-benefit assessment of aprotinin in cardiac surgical procedures
    Dobkowski, WB
    Murkin, JM
    DRUG SAFETY, 1998, 18 (01) : 21 - 41
  • [45] A Risk-Benefit Analysis Is Coffee healthy?
    Richling, Elke
    Habermeyer, Michael
    CHEMIE IN UNSERER ZEIT, 2014, 48 (01) : 12 - 20
  • [46] RISK-BENEFIT AND COST-BENEFIT-ANALYSIS - REPLY
    NEMETZ, PN
    VINING, A
    POLICY SCIENCES, 1982, 14 (03) : 299 - 302
  • [47] A Risk-Benefit Assessment of Aprotinin in Cardiac Surgical Procedures
    Wojciech B. Dobkowski
    John M. Murkin
    Drug Safety, 1998, 18 : 21 - 41
  • [48] PHARMACOGENETICS OF ACUTE TREATMENT OF DEPRESSION AND ANXIETY IN CHILDREN AND ADOLESCENTS: IMPROVING THE RISK-BENEFIT RATIO FOR THE USE OF SSRIS IN THE PEDIATRIC POPULATION
    Kronenberg, Sefi
    Weizman, Abraham
    Frisch, Amos
    Michaelovsky, Elena
    Carmel, Miri
    Apter, Alan
    ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2012, 49 (01): : 38 - 39
  • [49] Risk-benefit and cost-benefit ratio in headache treatment
    Pini L.A.
    Cainazzo M.M.
    Brovia D.
    The Journal of Headache and Pain, 2005, 6 (4) : 315 - 318
  • [50] A Risk-Benefit Assessment of Octreotide in the Treatment of Acromegaly
    Aart Jan van der Lely
    Wouter W. de Herder
    Steven W. J. Lamberts
    Drug Safety, 1997, 17 : 317 - 324